Business Standard

After GST, pharma companies prefer Gujarat over tax havens

Gujarat FDA has seen a significant jump in number of investment proposals after GST

Pricing pressure, high costs dent pharma firms' margins
Premium

Sohini DasAneesh Phadnis Ahmedabad/Mumbai
The goods and services tax (GST) has proven to be a boon for the pharmaceutical industry in Gujarat, with a renewed interest among pharma companies to set up units here as the hilly states tax havens lose attractiveness. As per the local Food and Drug Control Administration (FDCA), they are handling 30-40 applications every week for brownfield and greenfield units since GST has been implemented, as against 10-12 per week earlier.

H G Koshia, commissioner, Gujarat FDCA, informed that data collected for the period between June 13 and September 12 shows that around 56 fresh proposals to set up pharmaceutical

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in